ID
33557
Description
Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2
Keywords
Versions (3)
- 12/12/18 12/12/18 -
- 12/20/18 12/20/18 -
- 12/20/18 12/20/18 -
Copyright Holder
GSK group of companies
Uploaded on
December 12, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032
Visit 20: Prior and Concomitant Medications/Non-Drug Therapies
- StudyEvent: ODM
Description
Prior and Concomitant Medications/Non-Drug Therapies
Description
Concomitant Medication
Data type
boolean
Description
including procedures and surgeries
Data type
boolean
Description
Trade name preferred
Data type
text
Description
Unit Dose
Data type
text
Description
Unit
Data type
text
Description
Frequency
Data type
text
Description
Route
Data type
text
Description
If AE/SAE enter Event Term
Data type
text
Description
AE/SAE Event Number
Data type
integer
Description
Start date
Data type
date
Description
Stop date
Data type
date
Description
Ongoing?
Data type
boolean
Description
Taken prior to study?
Data type
boolean
Similar models
Visit 20: Prior and Concomitant Medications/Non-Drug Therapies
- StudyEvent: ODM
No comments